Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial

OBJECTIVE: To assess whether reshaping of the immune balance by infusion of autologous natural regulatory T cells (nTregs) in patients after kidney transplantation is safe, feasible, and enables the tapering of lifelong high dose immunosuppression, with its limited efficacy, adverse effects, and hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Roemhild, Andy, Otto, Natalie Maureen, Moll, Guido, Abou-El-Enein, Mohamed, Kaiser, Daniel, Bold, Gantuja, Schachtner, Thomas, Choi, Mira, Oellinger, Robert, Landwehr-Kenzel, Sybille, Juerchott, Karsten, Sawitzki, Birgit, Giesler, Cordula, Sefrin, Anett, Beier, Carola, Wagner, Dimitrios Laurin, Schlickeiser, Stephan, Streitz, Mathias, Schmueck-Henneresse, Michael, Amini, Leila, Stervbo, Ulrik, Babel, Nina, Volk, Hans-Dieter, Reinke, Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576328/
https://www.ncbi.nlm.nih.gov/pubmed/33087345
http://dx.doi.org/10.1136/bmj.m3734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576328/
https://www.ncbi.nlm.nih.gov/pubmed/33087345
http://dx.doi.org/10.1136/bmj.m3734

Ejemplares similares